Welcome to our dedicated page for Alto Ingredients SEC filings (Ticker: ALTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Alto Ingredients, Inc. (NASDAQ: ALTO) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Alto Ingredients is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients, and its filings offer detailed insight into how it reports financial performance, segment results and material corporate events.
Investors can review current reports on Form 8-K, where Alto Ingredients discloses items such as quarterly results, director elections and resignations, annual meeting outcomes and interactions with The Nasdaq Stock Market regarding listing compliance. For example, the company has used Form 8-K to report financial results for periods ended March 31, June 30 and September 30, to announce changes to its board of directors, and to note when it regained compliance with Nasdaq Listing Rule 5550(a)(2).
In addition to 8-Ks, Alto Ingredients files periodic reports such as Form 10-Q and Form 10-K, which contain consolidated financial statements, segment information for Pekin Campus production, Western production, marketing and distribution, and corporate activities, as well as discussions of risk factors and the company’s use of non-GAAP measures like Adjusted EBITDA. These documents explain how the company defines Adjusted EBITDA and reconcile it to net income or loss.
On Stock Titan, Alto Ingredients’ filings are updated as they are made available on EDGAR. AI-powered tools summarize key points from lengthy filings, highlight important changes from prior periods and help readers quickly locate information on topics such as revenue composition, segment performance, capital structure and material events. Users can also review insider and ownership-related filings, where applicable, to better understand equity activity by officers, directors and significant shareholders.
By using this page, investors and researchers can examine Alto Ingredients’ official disclosures in one place, compare information across reporting periods and connect narrative commentary in press releases with the underlying SEC-filed data.
Alto Ingredients, Inc. COO Todd E. Benton reported a routine share disposition related to taxes, not an open-market trade. On the vesting of restricted stock, 25,359 shares of common stock were withheld at $4.79 per share to cover withholding taxes. After this tax-withholding transaction, Benton directly holds 184,130 shares of Alto Ingredients common stock, indicating he maintains a substantial equity position in the company.
Alto Ingredients, Inc. Chief Financial Officer Robert R. Olander reported a Form 4 transaction involving company common stock. On this date, 41,072 shares were withheld upon vesting of restricted stock to cover withholding taxes, a non-market tax-withholding disposition. After this event, he directly held 253,086 common shares.
Alto Ingredients, Inc. Chief Commercial Officer James R. Sneed reported an automatic share disposition related to taxes, not an open-market trade. On April 1, 2026, 22,265 shares of common stock were withheld at $4.79 per share to cover tax obligations upon vesting of restricted stock. After this tax-withholding event, Sneed directly held 440,926 shares of Alto Ingredients common stock.
Alto Ingredients President & CEO Bryon T. McGregor reported a routine tax-related share disposition. On the vesting of restricted stock, 73,062 shares of common stock were withheld at $4.79 per share to cover withholding taxes. After this non‑market transaction, he directly owned 957,882 common shares.
Alto Ingredients, Inc. reported that its CLO & Secretary, Graham M. Auste, had 32,902 shares of common stock withheld on April 1, 2026 to cover taxes due at the vesting of restricted stock. The shares were valued at $4.79 per share for this tax-withholding transaction.
This was not an open-market sale but a tax-withholding disposition, where the company retains shares to satisfy withholding obligations. After this event, Auste directly holds 253,173 shares of Alto Ingredients common stock, indicating he continues to maintain a substantial equity position.
Benton Todd E reported acquisition or exercise transactions in this Form 4 filing.
Alto Ingredients COO Todd E. Benton received a grant of 35,730 shares of Common Stock on March 17, 2026. The award was recorded at a price of $0.00 per share, indicating it is a compensation-related grant rather than an open-market purchase. Following this grant, his direct ownership increased to 209,489 shares of Alto Ingredients common stock.
Sneed James R reported acquisition or exercise transactions in this Form 4 filing.
Alto Ingredients, Inc. reported that Chief Commercial Officer James R. Sneed received a grant of 30,794 shares of Common Stock on March 17, 2026. The shares were awarded at no purchase price, increasing his directly held stake to 463,191 shares. This appears to be a routine equity compensation award rather than an open-market trade.
Olander Robert R. reported acquisition or exercise transactions in this Form 4 filing.
Alto Ingredients, Inc. reported that Chief Financial Officer Robert R. Olander received a grant of 35,730 shares of Common Stock on 2026-03-17. The award was recorded at a price of $0.0000 per share, indicating a compensation-related stock grant rather than a market purchase. Following this grant, Olander directly holds 294,158 shares of Alto Ingredients common stock.
Alto Ingredients, Inc. reported that its CLO & Secretary, Graham Auste M, received a grant of 30,794 shares of common stock as a compensation award. The shares were acquired at no cash cost per share. Following this grant, he directly owns 286,075 common shares.
Alto Ingredients, Inc. President & CEO Bryon T. McGregor received a grant of 100,108 shares of Common Stock as a compensation-related award. The shares were acquired at a stated price of $0.00 per share and are held directly. Following this grant, McGregor directly owns 1,030,944 Common Stock shares.